Symbols / CYTOF $0.07 +0.00% Altamira Therapeutics Ltd.

Healthcare • Biotechnology • Bermuda • OID
CYTOF Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Biotechnology
CEO Dr. Thomas Meyer Ph.D.
Exch · Country OID · Bermuda
Market Cap 414.37K
Enterprise Value 1.25M
Income -5.65M
Sales —
FCF (ttm) -2.10M
Book/sh 0.71
Cash/sh 0.00
Employees 11
Insider 10d —
IPO Aug 06, 2014
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E —
PEG —
P/S —
P/B 0.10
P/C —
EV/EBITDA —
EV/Sales —
Quick Ratio 0.09
Current Ratio 0.11
Debt/Eq 19.39
LT Debt/Eq —
EPS (ttm) -1.19
EPS next Y —
EPS Growth —
Revenue Growth —
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-03-31
Earnings (prior) 2026-03-31
ROA -45.75%
ROE -108.79%
ROIC —
Gross Margin 0.00%
Oper. Margin 0.00%
Profit Margin 0.00%
Shs Outstand 5.72M
Shs Float 4.12M
Insider Own 18.80%
Instit Own 4.00%
Short Float 1.35%
Short Ratio 0.52
Short Interest 50.63K
52W High 0.15
vs 52W High -51.01%
52W Low 0.05
vs 52W Low 45.00%
Beta 2.88
Impl. Vol. —
Rel Volume 0.00
Avg Volume 3.11K
Volume 2.00
Target (mean) —
Tgt Median —
Tgt Low —
Tgt High —
# Analysts —
Recom None
Prev Close $0.07
Price $0.07
Change 0.00%
About

Altamira Therapeutics Ltd. operates as a preclinical-stage biopharmaceutical company in Switzerland, Australia, the United States, and Europe. The company develops and supplies peptide-based nanoparticle technologies for efficient RNA delivery to extrahepatic tissues through xPhore platform; and offers Bentrio, a drug-free nasal spray for protection against airborne viruses and allergens It is also developing AM-401 for the treatment of KRAS driven cancer; AM-411 for the treatment of rheumatoid arthritis; and AM-125 that is in post phase II clinical trial for the intranasal treatment of vertigo. The company was formerly known as Auris Medical Holding Ltd. and changed its name to Altamira Therapeutics Ltd. in July 2021. The company was founded in 2003 and is based in Hamilton, Bermuda.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$0.07
Latest analyst target
3. DCF / Fair value
$-6.61
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.07
Low
—
High
—
Mean
—
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total Revenue
0.00
0.00
0.00
0.00
Operating Revenue
0.00
0.00
0.00
0.00
Cost Of Revenue
—
0.27
-82.73%
1.56
-36.46%
2.45
Reconciled Cost Of Revenue
—
0.27
-82.73%
1.56
-35.11%
2.40
Gross Profit
—
-0.08
+93.44%
-1.23
+48.44%
-2.38
Operating Expense
6.92
+4.86%
6.60
-65.00%
18.86
+150.93%
7.52
Research And Development
3.73
+10.32%
3.38
-77.93%
15.31
+337.01%
3.50
Selling General And Administration
3.07
-8.25%
3.34
-2.64%
3.43
-13.72%
3.98
Selling And Marketing Expense
—
0.07
-97.14%
2.57
+56.71%
1.64
General And Administrative Expense
3.07
-8.25%
3.34
-2.64%
3.43
-13.72%
3.98
Salaries And Wages
0.83
+13.55%
0.73
+8.07%
0.68
-54.98%
1.50
Other Gand A
2.18
-15.89%
2.60
-5.68%
2.75
+13.61%
2.42
Other Operating Expenses
-0.00
+98.33%
-0.27
-2641.84%
-0.01
+98.06%
-0.50
Total Expenses
6.92
+4.86%
6.60
-65.00%
18.86
+150.93%
7.52
Operating Income
-6.92
-4.86%
-6.60
+65.00%
-18.86
-150.93%
-7.52
Total Operating Income As Reported
-6.85
-4.05%
-6.58
+65.09%
-18.86
-150.93%
-7.52
EBITDA
-8.31
-22.05%
-6.81
+63.13%
-18.47
-151.36%
-7.35
Normalized EBITDA
-7.49
-21.67%
-6.16
+66.92%
-18.62
-151.47%
-7.40
Reconciled Depreciation
0.13
-4.31%
0.13
+6.66%
0.12
+49.03%
0.08
EBIT
-8.44
-21.55%
-6.94
+62.66%
-18.59
-150.21%
-7.43
Total Unusual Items
-0.82
-25.65%
-0.65
-529.90%
0.15
+164.61%
0.06
Total Unusual Items Excluding Goodwill
-0.82
-25.65%
-0.65
-529.90%
0.15
+164.61%
0.06
Special Income Charges
-0.24
0.00
+100.00%
-0.00
0.00
Other Special Charges
—
0.23
—
—
Restructuring And Mergern Acquisition
0.24
0.00
-100.00%
0.00
0.00
Net Income
-8.46
-96.41%
-4.31
+84.50%
-27.78
-48.85%
-18.66
Pretax Income
-8.46
-4.53%
-8.09
+58.59%
-19.54
-162.41%
-7.45
Net Non Operating Interest Income Expense
-0.02
+97.97%
-0.81
+1.77%
-0.83
-5972.34%
0.01
Interest Expense Non Operating
0.02
-98.28%
1.15
+21.34%
0.95
+6033.89%
0.02
Net Interest Income
-0.02
+97.97%
-0.81
+1.77%
-0.83
-5972.34%
0.01
Interest Expense
0.02
-98.28%
1.15
+21.34%
0.95
+6033.89%
0.02
Interest Income Non Operating
0.00
-99.01%
0.34
+181.14%
0.12
+305.24%
0.03
Interest Income
0.00
-99.01%
0.34
+181.14%
0.12
+305.24%
0.03
Other Income Expense
-1.52
-124.28%
-0.68
-547.98%
0.15
+164.61%
0.06
Other Non Operating Income Expenses
0.07
+324.26%
0.02
—
—
Gain On Sale Of Security
-0.58
+11.32%
-0.65
-526.54%
0.15
+166.69%
0.06
Tax Provision
0.00
0.00
+100.00%
-0.01
+93.57%
-0.13
Tax Rate For Calcs
0.00
0.00
-100.00%
0.00
-97.55%
0.00
Tax Effect Of Unusual Items
0.00
0.00
-100.00%
0.00
-93.52%
0.00
Net Income Including Noncontrolling Interests
-8.46
-96.41%
-4.31
+84.50%
-27.78
-48.85%
-18.66
Net Income From Continuing Operation Net Minority Interest
-8.46
-4.53%
-8.09
+58.57%
-19.53
-166.93%
-7.32
Net Income From Continuing And Discontinued Operation
-8.46
-96.41%
-4.31
+84.50%
-27.78
-48.85%
-18.66
Net Income Continuous Operations
-8.46
-4.53%
-8.09
+58.57%
-19.53
-166.93%
-7.32
Net Income Discontinuous Operations
0.00
-100.00%
3.79
+145.89%
-8.25
+27.30%
-11.34
Normalized Income
-7.64
-2.68%
-7.44
+62.19%
-19.68
-166.94%
-7.37
Net Income Common Stockholders
-8.46
-96.41%
-4.31
+84.50%
-27.78
-48.85%
-18.66
Diluted EPS
-2.99
+81.85%
-16.47
+96.16%
-428.90
+23.89%
-563.52
Basic EPS
-2.99
+81.85%
-16.47
+96.16%
-428.90
+23.89%
-563.52
Basic Average Shares
2.83
+476.54%
0.49
+978.83%
0.05
+37.50%
0.03
Diluted Average Shares
2.83
+476.54%
0.49
+978.83%
0.05
+37.50%
0.03
Diluted NI Availto Com Stockholders
-8.46
-96.41%
-4.31
+84.50%
-27.78
-48.85%
-18.66
Depreciation Amortization Depletion Income Statement
0.13
-4.31%
0.13
+6.66%
0.12
+282.87%
0.03
Depreciation And Amortization In Income Statement
0.13
-4.31%
0.13
+6.66%
0.12
+282.87%
0.03
Depreciation Income Statement
0.13
-4.31%
0.13
+6.66%
0.12
+282.87%
0.03
Earnings From Equity Interest
-0.77
-1656.67%
-0.04
0.00
0.00
Other Taxes
0.00
-69.46%
0.01
+335.25%
0.00
+321.70%
0.00
Rent And Landing Fees
0.06
+216.47%
0.02
+178.15%
0.01
-89.01%
0.06
Rent Expense Supplemental
0.06
+216.47%
0.02
+178.15%
0.01
-89.01%
0.06
Total Other Finance Cost
—
0.01
+794.61%
0.00
—
Line Item Trend 2023-12-31
Total Assets
9.14
Current Assets
1.45
Cash Cash Equivalents And Short Term Investments
0.73
Cash And Cash Equivalents
0.73
Cash Financial
0.73
Receivables
0.09
Accounts Receivable
0.00
Other Receivables
0.06
Taxes Receivable
0.03
Inventory
0.00
Raw Materials
0.26
Finished Goods
0.13
Prepaid Assets
0.34
Hedging Assets Current
0.29
Other Current Assets
-0.00
Total Non Current Assets
7.69
Net PPE
0.10
Gross PPE
1.11
Accumulated Depreciation
-1.02
Properties
0.00
Buildings And Improvements
0.41
Machinery Furniture Equipment
0.28
Other Properties
0.42
Goodwill And Other Intangible Assets
4.63
Other Intangible Assets
4.63
Investments And Advances
2.97
Long Term Equity Investment
2.87
Other Non Current Assets
—
Total Liabilities Net Minority Interest
1.47
Current Liabilities
1.06
Payables And Accrued Expenses
0.71
Payables
0.52
Accounts Payable
0.49
Other Payable
0.03
Current Accrued Expenses
0.19
Employee Benefits
0.41
Pensionand Other Post Retirement Benefit Plans Current
0.23
Current Debt And Capital Lease Obligation
0.12
Current Debt
0.02
Other Current Borrowings
—
Current Capital Lease Obligation
0.12
Current Deferred Liabilities
0.21
Current Deferred Revenue
0.21
Total Non Current Liabilities Net Minority Interest
0.41
Long Term Debt And Capital Lease Obligation
0.00
Long Term Capital Lease Obligation
0.00
Non Current Deferred Liabilities
0.00
Non Current Deferred Revenue
0.00
Non Current Deferred Taxes Liabilities
0.00
Stockholders Equity
7.68
Common Stock Equity
7.68
Capital Stock
0.00
Common Stock
0.00
Share Issued
1.48
Ordinary Shares Number
1.48
Treasury Shares Number
0.00
Additional Paid In Capital
23.89
Retained Earnings
-21.35
Gains Losses Not Affecting Retained Earnings
5.13
Other Equity Adjustments
5.13
Total Equity Gross Minority Interest
7.68
Total Capitalization
7.68
Working Capital
0.40
Invested Capital
7.68
Total Debt
0.12
Net Debt
—
Capital Lease Obligations
0.12
Net Tangible Assets
3.05
Tangible Book Value
3.05
Available For Sale Securities
0.10
Derivative Product Liabilities
—
Duefrom Related Parties Current
0.00
Foreign Currency Translation Adjustments
0.18
Interest Payable
0.00
Investmentin Financial Assets
0.10
Investmentsin Associatesat Cost
2.87
Other Equity Interest
4.22
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Operating Cash Flow
-6.11
+52.28%
-12.81
-40.90%
-9.09
+39.21%
-14.96
Cash Flow From Continuing Operating Activities
-6.11
+52.28%
-12.81
-40.90%
-9.09
+39.21%
-14.96
Net Income From Continuing Operations
-8.46
-96.41%
-4.31
+84.50%
-27.78
-48.85%
-18.66
Depreciation Amortization Depletion
0.13
-4.31%
0.13
+6.66%
0.12
+49.03%
0.08
Depreciation
0.13
-4.31%
0.13
+6.66%
0.12
+49.03%
0.08
Depreciation And Amortization
0.13
-4.31%
0.13
+6.66%
0.12
+49.03%
0.08
Other Non Cash Items
0.25
+105.33%
-4.67
-344.48%
1.91
+900.52%
0.19
Pension And Employee Benefit Expense
0.06
+32.07%
0.05
-59.51%
0.11
+58.49%
0.07
Stock Based Compensation
0.53
+26.00%
0.42
+17.64%
0.36
-72.80%
1.32
Asset Impairment Charge
0.00
0.00
-100.00%
12.98
+675.61%
1.67
Deferred Tax
0.00
+100.00%
-0.11
-927.52%
-0.01
-145.73%
0.02
Deferred Income Tax
0.00
+100.00%
-0.11
-927.52%
-0.01
-145.73%
0.02
Operating Gains Losses
1.41
+217.66%
0.44
+209.07%
-0.41
-288.05%
0.22
Gain Loss On Investment Securities
—
0.15
+132.21%
-0.47
-205.08%
0.45
Net Foreign Currency Exchange Gain Loss
0.57
+185.66%
0.20
+515.94%
-0.05
+84.21%
-0.31
Change In Working Capital
0.03
+100.60%
-4.72
-226.63%
3.73
+1799.41%
0.20
Change In Receivables
-0.28
-1871.89%
0.02
+114.43%
-0.11
+70.84%
-0.37
Change In Inventory
0.00
+100.00%
-0.36
-141.08%
0.87
+194.39%
-0.92
Change In Prepaid Assets
0.14
-35.72%
0.22
-75.55%
0.90
+163.18%
-1.42
Change In Payables And Accrued Expense
0.16
+103.58%
-4.60
-321.91%
2.07
-28.68%
2.91
Change In Accrued Expense
0.10
+110.95%
-0.93
-223.59%
0.75
+344.15%
-0.31
Change In Payable
0.06
+101.72%
-3.67
-377.64%
1.32
-58.83%
3.21
Investing Cash Flow
-0.12
-107.17%
1.61
+171.70%
-2.24
+41.51%
-3.83
Cash Flow From Continuing Investing Activities
-0.12
-107.17%
1.61
+171.70%
-2.24
+41.51%
-3.83
Net PPE Purchase And Sale
-0.10
0.00
0.00
0.00
Purchase Of PPE
-0.10
0.00
0.00
0.00
Capital Expenditure
-0.10
—
-2.24
+38.33%
-3.64
Net Investment Purchase And Sale
-0.02
-240.40%
0.01
0.00
+100.00%
-0.20
Purchase Of Investment
—
—
—
-0.20
Sale Of Investment
—
0.01
0.00
—
Net Business Purchase And Sale
0.00
-99.99%
1.60
0.00
0.00
Purchase Of Business
0.00
+100.00%
-0.55
0.00
0.00
Net Intangibles Purchase And Sale
0.00
0.00
+100.00%
-2.24
+38.33%
-3.64
Purchase Of Intangibles
0.00
0.00
+100.00%
-2.24
+38.33%
-3.64
Net Other Investing Changes
—
—
—
-0.20
Financing Cash Flow
6.51
-44.97%
11.82
+14.82%
10.30
+42.29%
7.24
Cash Flow From Continuing Financing Activities
6.51
-44.97%
11.82
+14.82%
10.30
+42.29%
7.24
Net Issuance Payments Of Debt
-0.14
-111.80%
1.17
-81.18%
6.20
+8354.22%
-0.08
Issuance Of Debt
0.00
-100.00%
2.78
-56.00%
6.32
0.00
Repayment Of Debt
-0.14
+91.47%
-1.61
-1249.84%
-0.12
-59.18%
-0.08
Long Term Debt Issuance
—
—
—
0.00
Long Term Debt Payments
-0.14
-7.25%
-0.13
-7.37%
-0.12
-484.80%
-0.02
Net Long Term Debt Issuance
-0.14
-7.25%
-0.13
-7.37%
-0.12
-484.80%
-0.02
Short Term Debt Issuance
0.00
-100.00%
2.78
-56.00%
6.32
0.00
Short Term Debt Payments
0.00
+100.00%
-1.49
0.00
+100.00%
-0.05
Net Short Term Debt Issuance
0.00
-100.00%
1.30
-79.50%
6.32
+11660.02%
-0.05
Net Common Stock Issuance
—
1.19
—
—
Cash Dividends Paid
0.00
0.00
0.00
0.00
Proceeds From Stock Option Exercised
7.37
-36.96%
11.69
+181.83%
4.15
-44.57%
7.49
Net Other Financing Charges
-0.72
+18.00%
-0.88
-2254.42%
-0.04
+78.33%
-0.17
Changes In Cash
0.28
-55.31%
0.62
+159.45%
-1.04
+91.00%
-11.56
Effect Of Exchange Rate Changes
-0.01
-111.48%
0.10
+514.98%
-0.02
-107.53%
0.32
Beginning Cash Position
0.73
+4309.00%
0.02
-98.46%
1.08
-91.23%
12.32
End Cash Position
1.00
+36.11%
0.73
+4309.00%
0.02
-98.45%
1.08
Free Cash Flow
-6.22
+51.48%
-12.81
-13.01%
-11.34
+39.04%
-18.60
Common Stock Issuance
—
1.19
—
—
Earnings Losses From Equity Investments
0.77
+1656.67%
0.04
0.00
0.00
Interest Paid CFF
-0.01
+92.92%
-0.17
-708.44%
-0.02
-404.67%
-0.00
Interest Received CFI
0.00
+491.81%
0.00
-44.63%
0.00
0.00
Issuance Of Capital Stock
—
1.19
—
—
Sale Of Business
0.00
-99.99%
2.14
0.00
0.00
SEC Filings

No SEC filings found for this symbol (may be non-US or ticker not in SEC index).

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category